Skip to main content
SpringerLink
Log in

Exercise After Prostate Cancer Diagnosis

  • Chapter
  • First Online:
Exercise and Cancer Survivorship

Abstract

PCa is the second most commonly diagnosed cancer in men. Though often curable or treatable with an excellent long-term survival, many therapeutic options reduce health-related QoL. Exercise and regular PA have been demonstrated as beneficial throughout the continuum of the disease. Clinically important benefits have been observed particularly during the active treatment phase. Several recent intervention trials have investigated the effects of different exercise modalities (e.g., aerobic exercise, resistance training) during treatment on patient health-related QoL with promising results. Given the observed benefits, the issue of exercise adherence is becoming the focal point of studies as researchers strive to initiate a chronic health behavior change of increased PA to maintain exercise benefits beyond the acute intervention phase. This chapter reviews the current body of literature on exercise during PCa treatment and provides recommendations for future studies, implications for clinical practice, and preliminary recommendations for exercise prescription.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society, Cancer Facts & Figures 2008, 1–72, 2008.

    Google Scholar 

  2. Canadian Cancer Society/National Cancer Institute of Canada. (2008) Canadian Cancer Statistics, pp. 1–72.

    Google Scholar 

  3. Quinn M, Babb P. (2002) Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. Br J Urol Int 90:162–173.

    CAS  Google Scholar 

  4. Hsing A, Tsao WL, Devesa SS. (1999) International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85:60–67.

    Article  Google Scholar 

  5. National Comprehensive Cancer Network, NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer V.I. 2008, 1–44, 2008.

    Google Scholar 

  6. Fowler FJ, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. (1995) Effect of radical prostatectomy for prostate cancer on patient quality of life: Results from a medicare survey. Urology 45:1007–1115.

    Article  PubMed  Google Scholar 

  7. Moore KN, Estey A. (1999) The early post-operative concerns of men after radical prostatectomy. J Adv Nurs 29:1121–1129.

    Article  PubMed  CAS  Google Scholar 

  8. Haythornthwaite JA, Raja SN, Fisher B, Frank SM, Brendler CB, Shir Y. (1998) Pain and quality of life following radical retropubic prostatectomy. J Urol 160:1761–1764.

    Article  PubMed  CAS  Google Scholar 

  9. Meuleman E. (2003) Erectile function after radical prostatectomy: a review. Eur Urol 43:95–102.

    Article  PubMed  CAS  Google Scholar 

  10. Peschel RE, Colberg JW. (2003) Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 4:233–241.

    Article  PubMed  Google Scholar 

  11. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH. (1995) Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273:129–135.

    Article  PubMed  CAS  Google Scholar 

  12. Helgason AR, Adolfsson J, Dickman P, Fredrikson M, Arver S, Steineck G. (1996) Waning sexual function – the most important disease-specific distress for patients with prostate cancer. Br J Cancer 73:1417–1421.

    Article  PubMed  CAS  Google Scholar 

  13. Klotz L, Kiberl AS, Sanda M, Thompson I, Clarke N (2008) Surveillance Therapy Against Radical Treatment Trial (START), September 5, 2008.

    Google Scholar 

  14. Kennedy TJ, Sonneland AM, Marlett MM, Troup RH. (1992) Luteinizing hormone-releasing hormone downstaging of clinical stage C prostate cancer. J Urol 147:891–893.

    PubMed  CAS  Google Scholar 

  15. Macfarlane MT, Abi-Aad A, Stein A, Danella J, Belldegrum A, deKernion JB. (1993) Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer. J Urol 150:132–134.

    PubMed  CAS  Google Scholar 

  16. Oesterling JE, Andrews PE, Suman VJ, Zincke H, Myers RP. (1993) Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor. J Urol 149:779–782.

    PubMed  CAS  Google Scholar 

  17. Strum SE, McDermed JE, Scholz MC, Johnson H, Tisman G. (1997) Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade. Br J Urol 79:933–941.

    PubMed  CAS  Google Scholar 

  18. Daniell HW, Dunn SR, Ferguson DW, Lomas G, Niazi Z, Stratte PT. (2000) Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol 163: 181–186.

    Article  PubMed  CAS  Google Scholar 

  19. Smith MR, Finkelstein JS, McGovern FJ, Zietman AL, Fallon MA, Schoenfeld DA, Kantoff PW. (2002) Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 87:599–603.

    Article  PubMed  CAS  Google Scholar 

  20. Mittan D, Lee S, Miller E, Perez RC, Basler JW, Bruder JM. (2002) Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab 87:3656–3661.

    Article  PubMed  CAS  Google Scholar 

  21. Alibhai SMH, Gogov S, Allibhai Z. (2006) Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 60:201–215.

    Article  PubMed  Google Scholar 

  22. Chander S, Choo R, Danjoux C, Morton G, Pearse A, Deboer G, Szumacher E, Loblaw A, Cheung P, Woo T. (2005) Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery. Int J Radiat Oncol Biol Phys 62:719–724.

    Article  PubMed  CAS  Google Scholar 

  23. Stoch SA, Parker RA, Chen L, Bubley G, Ko Y, Vincellette A, Greenspan SL. (2001) Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 86:2787–2791.

    Article  PubMed  CAS  Google Scholar 

  24. Preston DM, Torrens JI, Harding P, Howard RS, Duncan WE, Mcleod DG. (2002) Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss. Prost Cancer Prost Dis 5:304–310.

    Article  CAS  Google Scholar 

  25. Pickett M, Bruner DW, Joseph A, Burgraf V. (2000) Prostate cancer elder alert: living with treatment choices and outcomes. J Gerontol Nurs 26:22–34.

    PubMed  CAS  Google Scholar 

  26. Cassileth BR, Soloway MS, Vogelzang NJ, Chou JM, Schellhammer PD, Seidmon EJ, Kennealey GT. (1992) Quality of life and psychosocial status in stage D prostate cancer. Qual Life Res 1:323–330.

    Article  PubMed  CAS  Google Scholar 

  27. Cleary PD, Morrissey G, Oster G. (1995) Health-related quality of life in patients with advanced prostate cancer. Qual Life Res 4:207–220.

    Article  PubMed  CAS  Google Scholar 

  28. Alibhai SMH, Rahman S, Warde PR, Jewett MA, Jaffer T, Cheung AM. (2006) Prevention and management of osteoporosis in men receiving androgen deprivation therapy: a survey of urologists and radiation oncologists. Urology 68:126–131.

    Article  PubMed  Google Scholar 

  29. Basaria S, Lieb JI, Tang§ AM, DeWeese T, Carducci M, Eisenberger M, Dobs AS. (2002) Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrin 56:779–786.

    Article  CAS  Google Scholar 

  30. Soyupek F, Soyupek H, Ozorak A. (2008) Androgen deprivation therapy for prostate cancer: effects on hand function. Urol Oncol 26:141–146.

    PubMed  CAS  Google Scholar 

  31. Mottet N, Prayer-Galetti T, Hammerer P, Kattan MW, Tunn U. (2006) Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer. Br J Urol Int 98:20–27.

    Google Scholar 

  32. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Theodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA. (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502–1512.

    Article  PubMed  CAS  Google Scholar 

  33. Berthold DR, Pond GR, Roessner M, de Wit R, Eisenberger M, Tannock IF. (2008) Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study. Clin Cancer Res 14:2763–2767.

    Article  PubMed  CAS  Google Scholar 

  34. Picus J, Schultz M. (1999) Docetaxel (taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: preliminary Results. Semin Oncol 26:14–18.

    PubMed  CAS  Google Scholar 

  35. Casperson CJ, Powell KE, Christenson GM. (1985) Physical activity, exercise, and physical fitness: definition and distinctions for health-related research. Public Health Rep 100:126–131.

    Google Scholar 

  36. Bouchard C, Shephard RJ, Physical Activity, Fitness, and Health: International Proceedings and Consensus Statement. Physical activity, fitness, and health: the model and key concepts, Windsor, ON: Human Kinetics, 1994, 77–88.

    Google Scholar 

  37. Paffenbarger RS, Hyde RT, Wing AL, Hsieh CC. (1986) Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 314:605–613.

    Article  PubMed  Google Scholar 

  38. Warburton DER, Nicol CW, Bredin SSD. (2006) Health benefits of PA: the evidence. Can Med Assoc J 174:801–809.

    Article  Google Scholar 

  39. Kampert JB, Blair SN, Barlow CE, Kohl HW III, Harold W. (1996) Physical activity, physical fitness, and all-cause and cancer mortality: a prospective study of men and women. Ann Epidemiol 6:452–457.

    Article  PubMed  CAS  Google Scholar 

  40. Friedenreich CM, Thune I. (2001) A review of PA and prostate cancer risk. Cancer Causes Control 12:461–475.

    Article  PubMed  CAS  Google Scholar 

  41. Min LI-. (2003) Physical activity and cancer prevention-data from epidemiologic studies. Med Sci Sports Exerc 35:1823–1827.

    Article  Google Scholar 

  42. Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ Willett WC. (2005) A prospective study of PA and incident and fatal prostate cancer. Arch Intern Med 165:1005–1010.

    Article  PubMed  Google Scholar 

  43. Tymchuk CN, Barnard RJ, Heber D, Aronson WJ. (2001) Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol 166:1185–1189.

    Article  PubMed  CAS  Google Scholar 

  44. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ. (2002) Effect of diet and exercise on serum insulin, IFG-I, and IFGBP-1 levels and growth of LNCaP cells in vitro. Cancer Causes Control 13:929–935.

    Article  PubMed  Google Scholar 

  45. Galvão DA, Taaffe DR, Spry N, Newton RU. (2007) Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prost Cancer Prost Dis 8:1–7.

    Google Scholar 

  46. Ngo TH, Barnard RJ, Leung P, Cohen P, Aronson WJ. (2003) Insulin-like growth factor (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival. Endocrinology 144:2319–2324.

    Article  PubMed  CAS  Google Scholar 

  47. Barnard RJ, Ngo TH, Leung PS, Aronson WJ, Golding LA. (2003) A low-fat diet and/or strenuous exercise alters the IFG axis in vivo and reduces prostate tumor cell growth in vitro. Prostate 56:201–206.

    Article  PubMed  Google Scholar 

  48. Leung PS, Aronson WJ, Ngo TH, Golding LA, Barnard RJ. (2004) Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro. J Appl Physiol 96:450–454.

    Article  PubMed  CAS  Google Scholar 

  49. Tymchuk CN, Tessier SB, Aronson WJ, Barnard RJ. (1998) Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen. Nutr Cancer 31:127–131.

    Article  PubMed  CAS  Google Scholar 

  50. Barnard RJ, Leung PS, Aronson WJ, Cohen P, Golding LA. (2007) A mechanism to explain how regular exercise might reduce the risk for clinical prostate cancer. Eur J Cancer Prev 16:415–421.

    Article  PubMed  CAS  Google Scholar 

  51. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D’Angelo ME, Wells GA. (May 1. 2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21:1653–1659.

    Article  PubMed  Google Scholar 

  52. Segal RJ, Reid R, Proulx C, Courneya K, Sigal R, Kenny G, Prud’homme S, Wells MG, (2009) Randomized controlled trial of resistance or aerobic exercise in men receiving radiation for prostate cancer. Journal of Clinical Oncology. 27: 344–351.

    Article  PubMed  Google Scholar 

  53. Galvao DA, Nosaka K, Taaffe DR, Spry N, Kristjanson LJ, McGuigan MR, Suzuki K, Kanemitsu Y, Newton RU. (2006) Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 38:2045–2052.

    Article  PubMed  Google Scholar 

  54. Duke University Medical Center. (2008) Exercise May Lead to Faster Prostate Tumor Growth, April 14, 2008.

    Google Scholar 

  55. Thorsen L, Courneya KS, Stevinson C, Fossa SD. (2008) A systematic review of PA in prostate cancer survivors: outcomes, prevalence, and determinants. Supportive Care Cancer 16:987–997.

    Article  Google Scholar 

  56. Durak EP, Harris J, Ceriale SM. (2001) The effects of exercise on quality of life improvement in cancer survivors: the Results of a national survey. J Exerc Online 4:21–28.

    Google Scholar 

  57. Stevinson C, Lawlor D, Fox K. (2004) Exercise interventions for cancer patients: systematic review of controlled trials. Cancer Causes Control 15:1035–1056.

    Article  PubMed  Google Scholar 

  58. Freedland SJ, Krupski TL, Moul JW. (2006) Update on outcomes research databases in prostate cancer 2006. Curr Opin Urol 16:168–172.

    Article  PubMed  Google Scholar 

  59. Freedland SJ, Aronson WJ, Kane CJ, Presti JC, Amling CL, Elashoff D, Terris MK. (2004) Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the shared equal access regional cancer hospital database study group. J Clin Oncol 22:446–453.

    Article  PubMed  Google Scholar 

  60. Chang SS, Duong DT, Wells N, Cole EE, Smith JA, Cookson MS. (2004) Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass index. J Urol 171:1861–1865.

    Article  PubMed  Google Scholar 

  61. Windsor PM, Nicol KF, Potter J. (2004) A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 101:550–557.

    Article  PubMed  Google Scholar 

  62. Monga U, Garber SL, Thornby J, Vallbona C, Kerrigan A, Monga TN, Zimmerman KP. (2007) Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy. Arch Phys Med Rehabil 88:1416–1422.

    Article  PubMed  Google Scholar 

  63. Smith JA, Jr. Soloway MS, Young MJ. (1999) Complications of advanced prostate cancer. Urology 54:8–14.

    Article  PubMed  Google Scholar 

  64. Williams MB, Hernandez J, Thompson I. (2005) Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength. J Urol 173:1067–1071.

    Article  PubMed  CAS  Google Scholar 

  65. Clay CA, Perera S, Wagner JM, Miller ME, Nelson JB, Greenspan SL. (2007) Physical function in men with prostate cancer on androgen deprivation therapy. Phys Ther 87:1325–1333.

    Article  PubMed  Google Scholar 

  66. Breunis H, Leach M, Naglie G, Tannock IF, Fleshner NE, Krahn M, Duff-Canning S, Tomlinson G, Warde P, Alibhai SM. (2008) Androgen deprivation therapy (ADT) and physical function in men with nonmetastatic prostate cancer. J Clin Oncol 27:4895.

    Google Scholar 

  67. Potosky AL, Reeve BB, Clegg LX, Hoffman RM, Stephenson RA, Albertsen PC, Gilliland FD, Stanford JL. (2002) Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Nat Cancer Inst 94:430–437.

    PubMed  Google Scholar 

  68. Daniell HW. (1997) Osteoporosis after orchiectomy for prostate cancer. J Urol 157:439–444.

    Article  PubMed  CAS  Google Scholar 

  69. Lee H, McGovern K, Finkelstein JS, Smith MR. (2005) Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma. Cancer 104:1633–1637.

    Article  PubMed  CAS  Google Scholar 

  70. Shahinian VB, Yong-Fang K, Freeman JL, Goodwin JS. (2005) Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352:154–164.

    Article  PubMed  CAS  Google Scholar 

  71. Oeffelein MG, Ricchuiti V, Conrad W, Resnick M. (2002) Skeletal fractures negatively correlate with overall survival in men with prostate cancer. J Urol 168:1005–1007.

    Article  Google Scholar 

  72. Carmack Taylor CL, Demoor C, Smith MA, Dunn AL, Basen-Engquist K, Nielsen I, Pettaway C, Sellin R, Massey P, Gritz ER. (2006) Active for life after cancer: A randomized trial examining a lifestyle PA program for prostate cancer patients. Psycho-Oncology 15:847–862.

    Article  PubMed  Google Scholar 

  73. Prochaska JO, Velicer WF. (1997) The transtheoretical model of health behavior change. Am J Health Prom 12:38–48.

    CAS  Google Scholar 

  74. Prochaska JO, DiClemente CC. (1983) Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 51:390–395.

    Article  PubMed  CAS  Google Scholar 

  75. Bandura A. (1986) Social foundations of thought and action: a social cognitive theory. Prentice Hall, Englewood Cliffs, NJ.

    Google Scholar 

  76. Bandura A. (1997) Self-efficacy: the exercise of control. W.H. Freeman and Company, New York.

    Google Scholar 

  77. Culos-Reed SN, Robinson JL, Lau H, O‘Connor K, Keats MR. (2007) Benefits of a PA intervention for men with prostate cancer. J Sport Exerc Psych 29:118–127.

    Google Scholar 

  78. Courneya KS, Friedenreich CM. (Fall 1997) Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors. J Altern Complement Med 3:215–226.

    Article  PubMed  CAS  Google Scholar 

  79. Culos-Reed SN, Robinson JW, Lau H, Stephenson L, Keats M, Norris S, Kline G. (2007) Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention Support Canre Cancer. 17 (online).

    Google Scholar 

  80. Berglund G, Bolund C, Gustafsson UL, Sjoden PO. (1994) A randomized study of a rehabilitation program for cancer patients: the ‘starting again’ group. Psycho-Oncology 3:109–120.

    Article  Google Scholar 

  81. Berglund G, Bolund C, Gustafsson UL, Sjoden PO. (1994) One-year follow-up of the ‘starting again’ group rehabilitation programme for cancer patients. Eur J Cancer 30A:1744–1751.

    Article  PubMed  CAS  Google Scholar 

  82. Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G. (2005) Physical exercise in cancer patients during and after medical treatment: A systematic review of randomized and controlled clinical trials. J Clin Oncol 23:3830–3842.

    Article  PubMed  Google Scholar 

  83. Courneya KS, Segal RJ, Reid RD, Jones LW, Malone SC, Venner PM, Parliament MB, Scott CG, Quinney HA, Wells GA. (2004) Three independent factors predicted adherence in a randomized controlled trial of exercise training among prostate cancer survivors. J Clin Epidem 57:571–579.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, University Health Network, Toronto, Ontario, Canada

    Daniel Santa Mina

  2. Population Studies and Surveillance, Cancer Care Ontario, University Avenue, Toronto, Ontario, Canada, M5G 2L7

    Paul Ritvo

  3. Ottawa Hospital Regional Cancer Center, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

    Roanne Segal

  4. Department of Kinesiology, Dalhousie University, Halifax, Nova Scotia, Canada

    N. Culos-Reed

  5. Division of Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontario, Canada, M5G 2C4

    Shabbir M.H. Alibhai

Authors
  1. Daniel Santa Mina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Ritvo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roanne Segal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Culos-Reed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shabbir M.H. Alibhai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Santa Mina .

Editor information

Editors and Affiliations

  1. Centre for Sport & Exercise Science, Sheffield Hallam University, Collegiate Crescent Campus, Sheffield, S10 2BP, United Kingdom

    John Saxton

  2. Medical School, Dept. Primary Care & General Practice, University of Birmingham, Birmingham, B15 2TT, United Kingdom

    Amanda Daley

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Santa Mina, D., Ritvo, P., Segal, R., Culos-Reed, N., Alibhai, S.M. (2010). Exercise After Prostate Cancer Diagnosis. In: Saxton, J., Daley, A. (eds) Exercise and Cancer Survivorship. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1173-5_7

Download citation

Publish with us

Policies and ethics

Search

Navigation